Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 207770 |
| Drug Identification Number | 02521539 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN AND TAZOBACTAM |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 4.5G 36G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1PSOIJ |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-23 |
| Estimated end date | 2023-11-17 |
| Actual end date | 2023-11-20 |
| Shortage status | Resolved |
| Updated date | 2023-11-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-11-21 | English | Compare |
| v5 | 2023-11-20 | French | Compare |
| v4 | 2023-11-20 | English | Compare |
| v3 | 2023-10-24 | English | Compare |
| v2 | 2023-10-23 | French | Compare |
| v1 | 2023-10-23 | English | Compare |
Showing 1 to 6 of 6